• Dr Elisa Ledet (Tulane Cancer Center, USA)
• Dr Georgios Lolas (University of Athens, Greece)
• Dr Kim Blenman (Yale Cancer Centre, USA)
• Dr Nicolas Robine (New York Genome Centre, USA)
• Prof Andreas Kaufmann (Charité-Universitätsmedizin, Berlin, Germany)
• Prof Aristotelis Chatziioannou (Biomedical Research Foundation of the Academy of Athens, Greece)
• Prof Chindo Hicks (Louisiana State University, USA)
• Prof David Bates (University of Nottingham, UK)
• Prof Godfrey Grech (University of Malta, Malta)
• Prof Jyotsna Batra (QUT/Australian Prostate Cancer Research Centre, Brisbane, Australia)
• Prof Kevin Gaston (University of Nottingham, UK)
• Prof Melissa Davis (Cornell Medicine, USA)
• Prof Oliver Sartor (Tulane Cancer Center, USA)
• Prof Olivier Elemento (Weill Cornell Medicine Englander Institute for Precision Medicine, USA)
• Prof Ramogola-Masire (University of Botswana, Botswana)
• Prof Ravi Mehrotra (Centre for Health Innovation and Policy (CHIP) Foundation, India)
• Prof Rui Reis (Barretos Cancer Hospital, Brazil & University of Minho, Braga, Portugal)
• Prof Rupert Ecker (TissueGnostics, Austria & QUT, Brisbane, Australia)
• Prof Solomon Rotimi (Covenant University, Nigeria)
• Prof Steven Reed (HDT Bio, USA)
• Prof Suzana Savkovic (Tulane Cancer Center, USA)
• Prof Victoria Belancio (Tulane Cancer Center, USA)
Abstract guidelines:
Interested presenters should submit an abstract of at least 250 words but not exceeding 300 words, in English, by 30 January 2023. The committee will review abstracts and send all decision letters by 6 February 2023. All abstracts will be published in a proceeding’s booklet.
Abstract Timeline:
30 January 2023 – Deadline for Abstract Submissions
6 February 2023 – Abstract Decision Letters Emailed
We hope you can find time in your busy schedule to be part of this ground-breaking international meeting and share your results, knowledge, and visions considering your outstanding academic achievements.
Looking forward to hearing from you.
Warm regards,
The Organising Committee